At the RNA level, ZnT1, ZnT9 and ZnT10 were significantly upregulated in human prostate cancer tissues compared to those in adjacent normal tissues, implying that intracellular zinc is diminished through this upregulation of zinc output transporters [110]. The gene discussed is SLC30A1; the disease is prostate cancer.